Global Research Reports

Personalized medicine is a concept that has the potential to transform medical interventions by providing effective and tailored therapies. The development of personalized medicine is a novel approach to introduce new dimension in medicine and healthcare industries. It includes the use of molecular analysis to achieve optimal medical outcome in management or diagnosis of patient’s disease. The main objective of personalized medicine is to identify most appropriate treatment option for patient population. Browse Full Research Report:  https://www.transparencymarketresearch.com/personalized-medicines-market.html The market of personalized medicine is witnessing positive growth owing to the advancement in technologies coupled with introduction of new technologies by key players. For example, in June 2013, Natural Molecular Testing Corporation launched expanded cardiac personalized medicine based on Luminex Corporation’s xMAP technology. In addition, introduction of technologie...

A new research report published by Transparency Market Research states that the global biopreservation market is set to grow in the coming years due to the rise in the number of biopreservation facilities. The report, titled “Biopreservation Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”, has been compiled using primary and secondary data. According to the research report, the global biopreservation market was valued at US$1.9 bn in 2012 and is expected to reach US$5.7 bn in 2019, growing at a remarkable CAGR of 16.70% from 2013 to 2019. The growth of the global biopreservation market will be a result of increasing biopreservation applications, upcoming new biopreservation facilities, and huge opportunities in developing economies. Browse Full Research Report:  https://www.transparencymarketresearch.com/biopreservation-market.html The global biopreservation market is segmented on the basis of product, application, and geography...

Transparency Market Research, a global market intelligence consultancy, has published a market study on the global transcriptomics technologies market for the 2013-2019 period. According to this report, the global transcriptomics technologies market will rise at a CAGR of 15.90% from 2013 to 2019 to reach a valuation of US$4.6 bn by the end of the forecast period. The market’s valuation in 2012 was US$1.65 bn. The report is titled “Transcriptomics Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”. The report says that the global transcriptomics technologies market will witness substantial growth in the coming years due to several reasons. Transcriptomics research involves studying the structure and function of RNA present in a cell.Presently, transcriptome analysis of several organisms is assisted using next-generation sequencing platforms in the preliminary phase followed by polymerase chain reactions, gene regulation technolo...

A new Transparency Market Research report states that the global companion diagnostics market stood at US$1.8 bn in 2013 and is predicted to reach US$5.6 bn by 2019. It is predicted to expand at a whopping CAGR of 18.0% between 2013 and 2019. The title of the report is “Companion Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019.” As per the report, the increasing demand for personalized medicines is the key factor fuelling the growth of the market for companion diagnostics. In addition, the rising occurrence of cancer globally and the reducing costs of drug development are also augmenting the growth of the market. Factors such as the rising focus on targeted therapies and the focus of pharmaceutical companies on the in-house advancement of companion diagnostics are also augmenting the growth of the market. Furthermore, the increasing new indication areas have emerged as a key opportunity in the market. Browse Full Research Repo...

Only a handful of companies such as bioMerieux, Inc., Abbott Laboratories, and Roche Diagnostics enjoy stronghold in the global automated immunoassay analyzers market. The lead of the companies is attributable to their expansive regional footprint and product portfolio, finds Transparency Market Research (TMR) in a new study. Furthermore, with a strong financial muscle, these companies are looking toward brighter prospects in the near future. As these companies gear to emerge at the fore, the global automated immunoassay analyzers market may witness roll out of novel products. Besides this, customization of existing products is on cards well. Riding on these factors the global automated immunoassay analyzers market is forecast to showcase robust expansion in the coming years. TMR has pegged the global automated immunoassay analyzers market at US$2.57 bn in 2016. Exhibiting a steady 4.5% CAGR between 2017 and 2025, the market is expected to reach US$3.78 bn by the end of 2025. Durin...

A recent intelligence study by Transparency Market Research (TMR) has detected that the global insulin pumps market is consolidated among top three companies, who accounted for more than 50% of the shares in 2016, whereas the rest of the market is fragmented, distributed among a large number of domestic and regional players. This report projects the demand in the global insulin pumps market to increment at a robust CAGR of 9.8% during the forecast period of 2017 to 2025, reaching a valuation of US$9,550.7 mn in 2025, notably up from its evaluated worth of US$4,180.4 mn in 2016. As far as the competitive landscape is concerned, the rivalry will intensify in the near future with the influx of several new vendors. In addition to that, the existing players are expected to add to their market shares via implementation of new models as well as mergers and acquisitions. Some of the key companies currently operating in the global insulin pumps market are Cellnovo Group SA, Medtronic, F. ...

The global dental implants market that has been analyzed in a recent research report by Transparency Market Research (TMR) demonstrates a largely consolidated vendor landscape. This is because of several large players that operate globally and a few small players that operate in regional markets. Some of the prominent names operating in the global market for dental implants are Straumann Holding AG, Dentsply Sirona Inc., Henry Schein Inc., Zimmer Biomet Holdings Inc., 3M Health Care, Danaher Corporation, Ivoclar Vivadent AG, and AVINENT Implant System S.L. The global dental implants market is projected to expand at a modest CAGR of 6.9% between 2017 and 2025. This will result in the market to become worth US$6.54 bn by 2025 increasing from its valuation of US$3.60 bn in 2016. Browse Full Research Report:  https://www.transparencymarketresearch.com/dental-implants-market.html Favorable Physical Properties of Titanium Boost Demand By product type, endosteal implants...

Prominent participants in the global non-vascular stents market are C. R. Bard, Inc., Boston Scientific Corporation, Cook Group Incorporated, Merit Medical Systems, Inc., Taewoong Medical Co., Ltd., Abbott Laboratories, Olympus Corporation, ELLA - CS, Medi-Globe Corporation, CONMED Corporation, M.I.TECH, and Allium Medical Solutions Ltd. At present the market is characterized by stiff competition between numerous local players and a few dominant international players. It has been noticed that the smaller local players have managed to dent shares of their global counterparts, and hence are posing a challenge to them. As per a report by Transparency Market Research, the global non-vascular stents market will expand at a steady pace by growing at a CAGR of 5.0% from 2017 to 2025. At this rate, the market will likely become worth US$730.5 mn by 2025 from US$475.0 mn in 2016. Browse Full Research Report:  https://www.transparencymarketresearch.com/non-vascular-stents-market.htm...

The global diabetic neuropathy market is semi-consolidated in which the prominent players hold limited share. The competition among the existing global and local manufacturers of diabetic neuropathy drugs is robust with most focused on research and development of better neuropathy drugs sans the complications and infections associated with their use. Boehringer, for example, has collaborated with Eli Lilly to develop new drugs to help overcome the complications caused by diabetes. Other popular strategies leveraged by the keen leading players in the global diabetic neuropathy market are acquisitions. Novartis AG, for instance, acquired Australia-based Spinifex Pharmaceuticals, Inc., to grow its portfolio of neuropathic pain treatments. Some of the prominent names operating in the global diabetic neuropathy market are Pfizer, Inc., Johnson & Johnson, Boehringer Ingelheim GmbH, NeuroMetrix, Inc., Astellas Pharma Inc., Eli Lilly and Company, GlaxoSmithKline plc, Lupin Limite...

The global molecular diagnostics market is highly consolidated in nature, observes Transparency Market Research. The leading players accounted for a share of 54% in the overall market in 2015. F. Hoffman-La Roche Ltd., Abbott Laboratories, and Danaher Corporation have dominated the global market in the past few years. The broad product portfolio and strategic mergers and acquisitions have been the winning strategies of these players to remain dominant. According to the research report, the global molecular diagnostic market is estimated to reach a valuation of US$18.9 bn by the end of 2025 as compared to US$7.1 bn in 2016. Between the forecast years of 2016 and 2025, the global market is estimated to expand at a steady CAGR of 11.6%. Well-established Healthcare Infrastructure in North America Bodes Well for Regional Market On the basis of technology, the global molecular diagnostics market is segmented into PCR and real-time PCR, hybridization, microarray, transcription-med...

The global pyrogen testing market is exceptionally consolidated as a few players hold a dominant share in the overall market. The leading players, Thermofisher, Lonza Group, Charles River Laboratories International, Inc., and Merck KGaA, held a lion’s share of 51% in the global market in 2015. Transparency Market Research observes that these companies are expected to retain their leadership as they are focused on development products that are do not require rabbit pyrogen testing along with strategic mergers and acquisitions. The players are determined to retain their presence in the global competition and contribute significantly to soaring revenues through the forecast period. According to the research report by Transparency Market Research, the opportunity in the global pyrogen testing market is expected to be worth US$1,527.8 mn by the end of 2024 as compared to US$570.0 mn in 2015. During the forecast period of 2016 and 2024, the global market is expected to surge at a...

The global market for cervical dysplasia features a highly consolidated competitive landscape, with the top three companies accounting for over 76% of the overall market in 2015, observes a recent report by Transparency Market Research. These top vendors, namely Qiagen AG, Hologic Inc., and F. Hoffmann-La Roche Ltd, have strengthened their hold on the market owing to strategies such as collaboration with leading pharmaceutical and biotechnology companies and successful and focused R&D activities. Low product penetration clubbed with vast untapped growth prospects across developing economies is a key incremental opportunity for market players. Thus, companies could benefit from increased focus on strong promotional campaigns in developing economies where nearly 90% of cervical cancer deaths occur on an annual basis. Transparency Market Research estimates that the global cervical dysplasia market will exhibit a healthy CAGR of 7.0% over the period between 2016 and 2024. If ...

Becton Dickinson and Company Group plc., Baxter International Inc., Terumo Medical Corporation, and Medtronic are the top four players that dominate over half the prefilled syringes market. Transparency Market Research has noted that the global prefilled syringes market is highly dynamic and competitive and while the nature of the market is consolidated in developed regions owing to the presence of large players, it remains fragmented in most of the emerging markets with many small regional players. The global sales of prefilled syringes amounted to US$3.5 bn in 2015 and is projected to reach US$7.9 bn, expanding at a CAGR of 9.3% over the period of 2016 to 2024. In terms of prefilled syringes consumption, the market is expected to expand at a CAGR of 9.0% during the forecast period. Ambulatory Surgical Centers to Show Promising Growth over Forecast Period By application, the vaccines segment dominated the global prefilled syringes market, accounting for a collective share ...

Becton Dickinson and Company Group plc., Baxter International Inc., Terumo Medical Corporation, and Medtronic are the top four players that dominate over half the prefilled syringes market. Transparency Market Research has noted that the global prefilled syringes market is highly dynamic and competitive and while the nature of the market is consolidated in developed regions owing to the presence of large players, it remains fragmented in most of the emerging markets with many small regional players. The global sales of prefilled syringes amounted to US$3.5 bn in 2015 and is projected to reach US$7.9 bn, expanding at a CAGR of 9.3% over the period of 2016 to 2024. In terms of prefilled syringes consumption, the market is expected to expand at a CAGR of 9.0% during the forecast period. Ambulatory Surgical Centers to Show Promising Growth over Forecast Period By application, the vaccines segment dominated the global prefilled syringes market, accounting for a collective share ...

The global market for medical aesthetic devices is characterized by a highly consolidated competitive landscape, wherein the top two vendors, Mentor Worldwide LLC and Allergan Plc., collectively held a nearly 60% of the market in 2015, observes a recent report by Transparency Market Research. Mentor Worldwide LLC, the market leader with a 32% share in the global market, stayed ahead of the competition with the help of strategic collaborations and a strong emphasis on aesthetic products such as breast implants and body contouring. In September 2016, the company announced its plans for a new collaboration with Galderma, a medical solutions firm with strong operations in skin health. Under the collaboration, the companies plan to partner with Canadian surgeons to improve patient experience across innovative aesthetic procedures and solutions, broadening consumers' access to and awareness of aesthetic treatment options. Browse Full Research Report:  https://www.transpare...